Scholar Rock Holding Corporation 2QK.F Stock
Scholar Rock Holding Corporation Price Chart
Scholar Rock Holding Corporation 2QK.F Financial and Trading Overview
Scholar Rock Holding Corporation stock price | 12.9 EUR |
Previous Close | 7.75 EUR |
Open | 7.65 EUR |
Bid | 7.6 EUR x N/A |
Ask | 7.85 EUR x N/A |
Day's Range | 7.65 - 7.65 EUR |
52 Week Range | 4.52 - 11.5 EUR |
Volume | 15K EUR |
Avg. Volume | 0 EUR |
Market Cap | 421.87M EUR |
Beta (5Y Monthly) | 0.76338 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.92 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 63.25 EUR |
2QK.F Valuation Measures
Enterprise Value | 212.97M EUR |
Trailing P/E | N/A |
Forward P/E | -1.8935643 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | Infinity |
Price/Book (mrq) | 1.7394271 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -1.306 |
Trading Information
Scholar Rock Holding Corporation Stock Price History
Beta (5Y Monthly) | 0.76338 |
52-Week Change | 63.13% |
S&P500 52-Week Change | 20.43% |
52 Week High | 11.5 EUR |
52 Week Low | 4.52 EUR |
50-Day Moving Average | 6.76 EUR |
200-Day Moving Average | 8.11 EUR |
2QK.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 54.29M |
Float | 32.68M |
Short Ratio | N/A |
% Held by Insiders | 3.21% |
% Held by Institutions | 99.93% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -35.74% |
Return on Equity (ttm) | -82.97% |
Income Statement
Revenue (ttm) | 0 EUR |
Revenue Per Share (ttm) | 0 EUR |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | -89851000 EUR |
EBITDA | -163076000 EUR |
Net Income Avi to Common (ttm) | -165931008 EUR |
Diluted EPS (ttm) | -2.82 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 275.28M EUR |
Total Cash Per Share (mrq) | 5.07 EUR |
Total Debt (mrq) | 67.5M EUR |
Total Debt/Equity (mrq) | 29.52 EUR |
Current Ratio (mrq) | 10.957 |
Book Value Per Share (mrq) | 4.398 |
Cash Flow Statement
Operating Cash Flow (ttm) | -133183000 EUR |
Levered Free Cash Flow (ttm) | -67912752 EUR |
Profile of Scholar Rock Holding Corporation
Country | Germany |
State | MA |
City | Cambridge |
Address | 301 Binney Street |
ZIP | 02142 |
Phone | 857 259 3860 |
Website | https://scholarrock.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 114 |
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients suffering from a range of serious diseases, including neuromuscular disorders, cancer, fibrosis, and iron-restricted anemia. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Q&A For Scholar Rock Holding Corporation Stock
What is a current 2QK.F stock price?
Scholar Rock Holding Corporation 2QK.F stock price today per share is 12.9 EUR.
How to purchase Scholar Rock Holding Corporation stock?
You can buy 2QK.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Scholar Rock Holding Corporation?
The stock symbol or ticker of Scholar Rock Holding Corporation is 2QK.F.
Which industry does the Scholar Rock Holding Corporation company belong to?
The Scholar Rock Holding Corporation industry is Biotechnology.
How many shares does Scholar Rock Holding Corporation have in circulation?
The max supply of Scholar Rock Holding Corporation shares is 83.24M.
What is Scholar Rock Holding Corporation Price to Earnings Ratio (PE Ratio)?
Scholar Rock Holding Corporation PE Ratio is now.
What was Scholar Rock Holding Corporation earnings per share over the trailing 12 months (TTM)?
Scholar Rock Holding Corporation EPS is -1.92 EUR over the trailing 12 months.
Which sector does the Scholar Rock Holding Corporation company belong to?
The Scholar Rock Holding Corporation sector is Healthcare.